Answers are grounded in this paper and cite their sources.
Background: Although recombinant human soluble thrombomodulin (rhTM) is reportedly effective for treating disseminated intravascular coagulation (DIC), the prognosis for DIC patients remains still poor.
No takes yet. Share an insight, caveat, or question.
Kawano et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: